Sigma Planning Corp’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-12,471
| Closed | -$698K | – | 887 |
|
2018
Q3 | $698K | Sell |
12,471
-234
| -2% | -$13.1K | 0.04% | 379 |
|
2018
Q2 | $641K | Sell |
12,705
-468
| -4% | -$23.6K | 0.04% | 389 |
|
2018
Q1 | $648K | Sell |
13,173
-327
| -2% | -$16.1K | 0.05% | 365 |
|
2017
Q4 | $695K | Sell |
13,500
-576
| -4% | -$29.7K | 0.05% | 343 |
|
2017
Q3 | $734K | Buy |
14,076
+576
| +4% | +$30K | 0.06% | 325 |
|
2017
Q2 | $698K | Buy |
13,500
+3,861
| +40% | +$200K | 0.07% | 324 |
|
2017
Q1 | $485K | Buy |
+9,639
| New | +$485K | 0.05% | 405 |
|
2016
Q4 | – | Sell |
-4,818
| Closed | -$240K | – | 772 |
|
2016
Q3 | $240K | Buy |
+4,818
| New | +$240K | 0.03% | 582 |
|
2016
Q1 | – | Sell |
-3,717
| Closed | -$200K | – | 728 |
|
2015
Q4 | $200K | Sell |
3,717
-1,446
| -28% | -$77.8K | 0.03% | 599 |
|
2015
Q3 | $255K | Sell |
5,163
-19,419
| -79% | -$959K | 0.04% | 473 |
|
2015
Q2 | $1.43M | Buy |
24,582
+2,967
| +14% | +$173K | 0.2% | 131 |
|
2015
Q1 | $1.24M | Sell |
21,615
-1,221
| -5% | -$70.2K | 0.16% | 147 |
|
2014
Q4 | $1.15M | Buy |
+22,836
| New | +$1.15M | 0.15% | 160 |
|